1)Matsuda R, Kezuka T, Umazume A et al:Clinical profile of anti-myelin oligodendrocyte glycoprotein antibody seropositive cases of optic neuritis. Neuroophthalmology 39:213-219, 2015
2)Jarius S, Ruprecht K, Kleiter I et al:MOG-IgG in NMO and related disorders:a multicenter study of 50 patients. Part 2:Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 13:280, 2016
3)Kezuka T, Ishikawa H:Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis. Jpn J Ophthalmol 62:101-108, 2018
4)宮内彰彦・門田行史:抗ミエリン希突起膠細胞糖蛋白抗体と小児脱髄疾患.神眼35:404-411,2018
5)De Mol CL, Wong Y, van Pelt ED et al:The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Mult Scler 26:806-814, 2020
6)Miyauchi A, Monden Y, Watanabe M et al:Persistent presence of the anti-myelin oligodendrocyte glycoprotein autoantibody in a pediatric case of acute disseminated encephalomyelitis followed by optic neuritis. Neuropediatrics 45:196-199, 2014
7)向井宏樹・横田 元:抗MOG抗体関連疾患.画像診断39:293-301,2019
8)Weber MS, Derfuss T, Metz I et al:Defining distinct features of anti-MOG antibody associated central nervous system demyelination. Ther Adv Neurol Disord 11:1-15, 2018
9)Di Pauli F, Mader S, Rostasy K et al:Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immumol 138:247-254, 2011
10)高島光平・高野知行・松井 潤・他:血漿交換を要した抗myelin oligodendrocyte glycoprotein抗体陽性の急性散在性脳脊髄炎に続発する視神経炎の男児例.脳と発達50:276-280,2018
11)Bruijstens AL, Lechner C, Flet-Berliac L et al:E. U. paediatric MOG consortium consensus:Part 1-Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol 29:2-13, 2020